31 completed, 19 unknown, 6 terminated, 3 withdrawn. 17 Not applicable, 15 Phase 4, 7 Phase 2, 7 Phase 3, 2 Early Phase 1.
Follow Ovarian Hyperstimulation Syndrome: new trials by email Literature Review of Ovarian Hyperstimulation Syndrome trials Research Report on Ovarian Hyperstimulation Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Myo-Inositol for Ovarian Stimulation and ICSI Outcomes in Women With PCOS Myo-Inositol, Folic Acid - Polycystic Ovary Syndrome | Not applicable | Completed | Kafrelsheikh University | 88 | 2024-05-15 | 2026-08-21 |
| The Letrozole Administration During Luteal Phase Letrozole, Polygeline, Sodium Chloride - Ovarian Hyperstimulation Syndrome | Phase 3 | Unknown | The Affiliated Hospital of Inner Mongolia Medical University | 50 | 2023-12-01 | 2023-07-20 |
| Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin Calcium Gluconate - Ovarian Hyperstimulation Syndrome | Not applicable | Completed | Minia University | 180 | 2022-10-01 | 2025-01-07 |
| Ovarian Hyperstimulation Syndrome Using Calcium Infusion Calcium intravenous infsuion, 0.9 % saline - Ovarian Hyperstimulation Syndrome | Not applicable | Unknown | Al-Azhar University | 200 | 2022-03-01 | 2022-02-22 |
| Real-world Evidence on Follitropin Delta Individual Dosing Follitropin delta - Infertility, Sterility | Recruiting | University of Luebeck | 850 | 2021-12-08 | 2025-03-30 | |
| Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy Identification of predictive factors - Ovarian Hyperstimulation Syndrome, Frozen-thawed Embryo Transfers | Completed | Centre Hospitalier Régional Metz-Thionville | 168 | 2019-11-01 | 2022-10-20 | |
| Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS Gonadotropin, Antagonist - Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | ClinAmygate | 300 | 2019-07-01 | 2019-11-21 |
| Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome Pregnyl (1,500) IU, 1.5 mL of normal saline - Ovarian Hyperstimulation Syndrome, Infertility, Female | Phase 4 | Unknown | Mount Sinai Hospital, Canada | 80 | 2019-05-01 | 2023-07-03 |
| Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response Fludrocortisone 0.1 Milligrams (mg), Bromocriptine - Ovarian Hyperstimulation Syndrome | Phase 2 | Completed | Ganin Fertility Center | 107 | 2019-04-01 | 2020-04-17 |
| Montelukast for Prevention & Treatment of OHSS dydrgesterone 10 mg( tab)/12hs/14 days, montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days - Ovarian Hyperstimulation Syndrome | Phase 2 | Suspended | Benha University | 20 | 2018-12-05 | 2022-09-21 |
| Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders Synarel, 0.2 Mg/Inh Nasal Spray, Estrofem, Utrogestan - Pregnancy Early, Miscarriage | Phase 4 | Unknown | Assaf-Harofeh Medical Center | 100 | 2017-12-29 | 2021-04-01 |
| The Influence of Timing of Cabergoline Initiation on Prevention of OHSS Late Cabergoline 0.5mg, Early Cabergoline 0.5mg - Ovarian Hyperstimulation Syndrome | Phase 3 | Unknown | Mona M Shaban | 75 | 2017-12-20 | 2018-04-10 |
| Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS IVM, Minimal stimulation IVF - No Condition | Not applicable | Unknown | CHA University | 240 | 2017-05-01 | 2020-03-24 |
| Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET Triptorelin for Injection, Recombinant Human Choriogonadotropin alfa Solution for Injection, Progesterone Soft Capsules - Ovarian Hyperstimulation Syndrome | Phase 3 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 252 | 2017-03-01 | 2017-03-06 |
| Preventive Application of GnRH Antagonist on Early OHSS GnRH antagonist, aspirin - Ovarian Hyperstimulation Syndrome, GnRH Antagonist | Phase 4 | Unknown | First Affiliated Hospital, Sun Yat-Sen University | 175 | 2017-01-01 | 2017-06-15 |
| The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome Minimal ovarian stimulation - Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome | Not applicable | Completed | Royan Institute | 120 | 2016-11-12 | 2021-04-20 |
| Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS Decapeptyl, hCG luteal support - Infertility | Not applicable | Unknown | Meir Medical Center | 50 | 2016-08-01 | 2016-07-12 |
| Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome bromocriptine, dexamethasone - Ovarian Hyperstimulation Syndrome | Phase 2 | Unknown | Sun Yat-sen University | 200 | 2016-08-01 | 2016-07-27 |
| Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response COAGO - Ovarian Hyperstimulation Syndrome, Hypercoagulability | Not applicable | Terminated | University Hospital, Lille | 1 | 2016-02-26 | 2019-10-04 |
| Medical Assistance for the Procreation and Risk of Thrombosis. ovarian stimulation - Ovarian Hyperstimulation Syndrome, Cardiovascular Diseases | Terminated | University Hospital, Brest | 129 | 2016-02-02 | 2020-07-10 |
Showing 20 of 61. Sign in to see all of them.
Polycystic Ovary Syndrome (12) · Infertility (8) · Infertility, Female (2) · Abortion, Spontaneous (1) · Ascites (1) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Endometriosis (1) · Infertility, Male (1) · Insulin Resistance (1) · Primary Ovarian Insufficiency (1) · Thrombophilia (1)
Adnexal Diseases (61) · Endocrine System Diseases (61) · Female Urogenital Diseases (61) · Female Urogenital Diseases and Pregnancy Complications (61) · Genital Diseases (61) · Genital Diseases, Female (61) · Gonadal Disorders (61) · Ovarian Diseases (61) · Urogenital Diseases (61) · Cysts (12) · Neoplasms (12) · Ovarian Cysts (12) · Genital Diseases, Male (1) · Glucose Metabolism Disorders (1) · Hematologic Diseases (1)
Triptorelin Pamoate (8) · Cabergoline (7) · Chorionic Gonadotropin (5) · Sodium Chloride (4) · cetrorelix (4) · Glycoprotein Hormones, alpha Subunit (3) · follitropin alfa (3) · Aspirin (2) · Bromocriptine (2) · Dexamethasone (2) · Estradiol (2) · Gonadotropin-Releasing Hormone (2) · LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (2) · Letrozole (2) · Leuprolide (2)
Instituto Valenciano de Infertilidad, IVI VALENCIA (3) · Merck KGaA, Darmstadt, Germany (3) · Royan Institute (3) · Chenshiling (2) · Eugonia (2) · Ferring Pharmaceuticals (2) · First Affiliated Hospital, Sun Yat-Sen University (2) · UConn Health (2) · Al-Azhar University (1) · Antalya IVF (1) · Assaf-Harofeh Medical Center (1) · Bagcilar Training and Research Hospital (1) · Benha University (1) · Bioroma (1) · CHA University (1)
Egypt (7) · China (6) · Spain (5) · United States (5) · France (3) · Iran (3) · Israel (3) · Turkey (Türkiye) (3) · Denmark (2) · Germany (2) · Greece (2) · Italy (2) · Belgium (1) · Canada (1) · Ireland (1)
Ashraf Moini, MD (2) · Lawrence Engmann, MD (2) · Marzieh Shiva, MD (2) · Shi-Ling Chen, M.D., Ph.D. (2) · Alfonso Bermejo, MD (1) · Amir Wiser, MD (1) · Antonio Pellicer, MD (1) · Ariel Hourvitz (1) · Assunta Iuliano, MD, PhD (1) · Azar Yahyaei, M.Sc. (1) · Claudio Benadiva, MD (1) · Didi D Braat, Prof. MD PhD (1)
PMID 33851429, PMID 17854523, PMID 20008886, PMID 20139430, PMID 21134950, PMID 21601197, PMID 22231013, PMID 23753114, PMID 23932181, PMID 25552412, PMID 25780518, PMID 27060174, PMID 28130435, PMID 28461237, PMID 28494798, PMID 29175067, PMID 31227286, PMID 37340371, PMID 39912435, PMID 41221041